Journey Medical Corporation announced that its CEO, Claude Maraoui, will participate in a fireside chat at A.G.P.'s Annual Virtual Healthcare Conference on May 20, 2026. The company specializes in developing and marketing FDA-approved prescription drugs for dermatological conditions and currently markets eight branded products. This participation highlights Journey Medical's ongoing engagement with investors and the healthcare community. The event offers an opportunity to discuss the company's strategy and recent developments.
Hamilton Lane reported a fourth-quarter EPS of $1.49, surpassing estimates for the fourth consecutive quarter, though its revenue of $193.56 million fell short of projections. For fiscal year 2026, the firm showed solid growth with assets rising 9% t...
Inventiva, a biopharmaceutical company developing oral therapy for metabolic dysfunction-associated steatohepatitis (MASH), announced its CEO Andrew Obenshain will present at the 2026 Jefferies Global Healthcare Conference in New York on June 3. The ...
LiquidStack, a Trane Technologies company, has commercially launched its GigaModular™ CDU platform designed for high-density AI data centers. The platform offers flexible, scalable liquid cooling capacity up to 14 MW, enabling operators to expand coo...
Electrolux Group has announced a fully underwritten rights issue of approximately SEK 9.06 billion, subject to approval at an Extraordinary General Meeting on May 27, 2026. The proceeds will finance growth initiatives, including a strategic partnersh...
XRP has experienced renewed volatility this week, trading between $1.35 and $1.55, driven by speculation around ETF activity and institutional interest, including mentions of Goldman Sachs. Regulatory progress with the U.S. CLARITY Act has added opti...
